| CIRAX | FBBAX | CIRAX / FBBAX | |
| Total Expense Ratio | 0.60 | 1.32 | 45% |
| Annual Report Gross Expense Ratio | 0.60 | 1.32 | 45% |
| Fund Existence | 24 years | 33 years | - |
| Gain YTD | 10.356 | -0.494 | -2,097% |
| Front Load | 4% | 6% | 61% |
| Min. Initial Investment | 250 | 1000 | 25% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 128B | 64.6M | 198,142% |
| Annual Yield % from dividends | 2.67 | 3.79 | 70% |
| Returns for 1 year | 13.39 | -1.64 | -815% |
| Returns for 3 years | 43.12 | 3.71 | 1,164% |
| Returns for 5 years | 43.59 | 3.63 | 1,201% |
| Returns for 10 years | 95.96 | 53.77 | 178% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| RGBCX | 42.76 | 0.19 | +0.45% |
| American Funds Global Balanced R-3 | |||
| REMYX | 24.99 | N/A | N/A |
| Russell Inv Emerging Markets Y | |||
| EQIAX | 17.63 | N/A | N/A |
| Allspring Emerging Markets Eq Advtg A | |||
| GAGPX | 13.31 | N/A | N/A |
| Goldman Sachs Em Mkts Eq Insghts P | |||
| SBHCX | 14.67 | N/A | N/A |
| Segall Bryant & Hamill Small Cap Cre Ret | |||